(Reuters) - Specialty Compounding Llc reached a settlement with the U.S. Food and Drug Administration on Wednesday, barring the company from producing and selling sterile drugs until it receives written approval from the agency.

via Reuters: Health News Read More Here..
No comments:
Post a Comment